Brian C. Shaffer

3.5k total citations
73 papers, 1.1k citations indexed

About

Brian C. Shaffer is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Immunology. According to data from OpenAlex, Brian C. Shaffer has authored 73 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Hematology, 22 papers in Public Health, Environmental and Occupational Health and 18 papers in Immunology. Recurrent topics in Brian C. Shaffer's work include Hematopoietic Stem Cell Transplantation (41 papers), Acute Lymphoblastic Leukemia research (18 papers) and Acute Myeloid Leukemia Research (15 papers). Brian C. Shaffer is often cited by papers focused on Hematopoietic Stem Cell Transplantation (41 papers), Acute Lymphoblastic Leukemia research (18 papers) and Acute Myeloid Leukemia Research (15 papers). Brian C. Shaffer collaborates with scholars based in United States, Spain and United Kingdom. Brian C. Shaffer's co-authors include Miguel‐Angel Perales, Katharine C. Hsu, Maria R. Baer, Susan E. Bates, Michael M. Gottesman, Chirayu Patel, Jean‐Pierre Gillet, Ann A. Jakubowski, Sergio Giralt and Jean-Benoît Le Luduec and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Infectious Diseases.

In The Last Decade

Brian C. Shaffer

62 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian C. Shaffer United States 18 418 377 310 235 197 73 1.1k
Kazuhiro Masuoka Japan 21 588 1.4× 326 0.9× 378 1.2× 198 0.8× 124 0.6× 50 1.1k
Andrea Mengarelli Italy 19 434 1.0× 279 0.7× 171 0.6× 161 0.7× 199 1.0× 64 1.0k
Roberta Schiavo Italy 19 399 1.0× 687 1.8× 402 1.3× 95 0.4× 213 1.1× 40 1.3k
Rémy Duléry France 17 489 1.2× 346 0.9× 196 0.6× 205 0.9× 187 0.9× 89 935
Jean Norden United Kingdom 18 432 1.0× 135 0.4× 412 1.3× 155 0.7× 261 1.3× 45 1.0k
Karima Yakouben France 19 459 1.1× 172 0.5× 172 0.6× 196 0.8× 90 0.5× 50 893
D Baume France 18 210 0.5× 340 0.9× 337 1.1× 172 0.7× 172 0.9× 44 1.0k
J.A. Gastaut France 16 514 1.2× 287 0.8× 190 0.6× 239 1.0× 149 0.8× 38 1.1k
Adan Rios United States 15 141 0.3× 465 1.2× 382 1.2× 136 0.6× 235 1.2× 67 1.2k
Mats Remberger Sweden 18 583 1.4× 398 1.1× 247 0.8× 185 0.8× 71 0.4× 37 1.1k

Countries citing papers authored by Brian C. Shaffer

Since Specialization
Citations

This map shows the geographic impact of Brian C. Shaffer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian C. Shaffer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian C. Shaffer more than expected).

Fields of papers citing papers by Brian C. Shaffer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian C. Shaffer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian C. Shaffer. The network helps show where Brian C. Shaffer may publish in the future.

Co-authorship network of co-authors of Brian C. Shaffer

This figure shows the co-authorship network connecting the top 25 collaborators of Brian C. Shaffer. A scholar is included among the top collaborators of Brian C. Shaffer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian C. Shaffer. Brian C. Shaffer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shaffer, Brian C., et al.. (2026). Atrial Fibrillation Following Autologous Stem Cell Transplantation in Multiple Myeloma. JACC CardioOncology. 8(1). 17–27.
2.
Modi, Dipenkumar, Yosra Aljawai, Todd E. DeFor, et al.. (2025). Matched unrelated vs haploidentical donor hematopoietic cell transplantation using posttransplant cyclophosphamide. Blood Advances. 10(1). 233–245. 1 indexed citations
3.
McCurdy, Shannon R., Scott R. Solomon, Brian C. Shaffer, et al.. (2025). Post-Transplant Cyclophosphamide Improves Survival in HLA-DPB1 Mismatched Unrelated Donor Allogeneic Transplantation. Transplantation and Cellular Therapy. 32(1). 74.e1–74.e14.
4.
Shaffer, Brian C., Mahasweta Gooptu, Todd E. DeFor, et al.. (2024). Post-Transplant Cyclophosphamide–Based Graft-Versus-Host Disease Prophylaxis Attenuates Disparity in Outcomes Between Use of Matched or Mismatched Unrelated Donors. Journal of Clinical Oncology. 42(28). 3277–3286. 20 indexed citations
5.
Fingrut, Warren, Eric Davis, Samantha Brown, et al.. (2024). Racial/ethnic disparities in availability of volunteer unrelated donors for allogeneic transplantation. Blood Advances. 8(11). 2753–2764. 6 indexed citations
6.
Shaffer, Brian C., Partow Kebriaei, Marcos de Lima, & Antonio Jiménez. (2024). Measurable residual disease testing and allogeneic hematopoietic cell transplantation for AML: adapting Pre-MEASURE to clinical practice. Bone Marrow Transplantation. 60(2). 128–134. 1 indexed citations
7.
Fingrut, Warren, Jessica Flynn, Eric Davis, et al.. (2023). Association between non-European ancestry, low socioeconomic status, and receipt of HLA-disparate allografts in adult BMT recipients. Blood Advances. 7(15). 3834–3837. 4 indexed citations
8.
Ploeg, Kattria van der, Rosa Sottile, Brian C. Shaffer, et al.. (2023). Emergence of human CMV-induced NKG2C+ NK cells is associated with CD8+ T-cell recovery after allogeneic HCT. Blood Advances. 7(19). 5784–5798. 5 indexed citations
9.
Fingrut, Warren, Eric Davis, Samantha Brown, et al.. (2023). Gender disparities in allograft access due to HLA-sensitization in multiparous women. Blood Advances. 8(2). 403–406. 2 indexed citations
10.
Lin, Andrew, Samantha Brown, Yeon Joo Lee, et al.. (2023). Patterns of CMV infection after letermovir withdrawal in recipients of posttransplant cyclophosphamide–based transplant. Blood Advances. 7(23). 7153–7160. 6 indexed citations
11.
Markova, Alina, Esperanza B. Papadopoulos, Stephen W. Dusza, et al.. (2023). Topical Ruxolitinib for Chronic Cutaneous GvHD: Promising Results of a Phase 2 Clinical Trial. Blood. 142(Supplement 1). 777–777. 1 indexed citations
12.
Lin, Andrew, Samantha Brown, Molly Maloy, et al.. (2022). Impact of omitting post-transplant minidose-methotrexate doses in allogeneic hematopoietic cell transplantation. Leukemia & lymphoma. 63(7). 1686–1693. 2 indexed citations
13.
Jiménez, Antonio, Krishna V. Komanduri, Samantha Brown, et al.. (2022). Improved GRFS after posttransplant cyclophosphamide-based vs ATG-based HLA-mismatched unrelated donor transplant. Blood Advances. 6(15). 4491–4500. 10 indexed citations
14.
Shah, Nishi, Parastoo B. Dahi, Doris M. Ponce, et al.. (2021). Hematopoietic Cell Transplantation is Feasible in Patients with Prior COVID-19 Infection. Transplantation and Cellular Therapy. 28(1). 55.e1–55.e5. 7 indexed citations
15.
Stern, Anat, Yiqi Su, Yeon Joo Lee, et al.. (2020). A Single-Center, Open-Label Trial of Isavuconazole Prophylaxis against Invasive Fungal Infection in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 26(6). 1195–1202. 36 indexed citations
16.
Shaffer, Brian C. & Katharine C. Hsu. (2020). Selection of allogeneic hematopoietic cell transplant donors to optimize natural killer cell alloreactivity. Seminars in Hematology. 57(4). 167–174. 8 indexed citations
17.
18.
Lin, Andrew, Molly Maloy, Yiqi Su, et al.. (2019). Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: Real‐world experience. Transplant Infectious Disease. 21(6). e13187–e13187. 65 indexed citations
19.
Rondon-Clavo, Carlos, Michael Scordo, Patrick Hilden, et al.. (2018). Early Fluid Overload Is Associated with an Increased Risk of Nonrelapse Mortality after Ex Vivo CD34-Selected Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 24(12). 2517–2522. 14 indexed citations
20.
Shaffer, Brian C., Jean‐Pierre Gillet, Chirayu Patel, et al.. (2012). Drug resistance: Still a daunting challenge to the successful treatment of AML. Drug Resistance Updates. 15(1-2). 62–69. 213 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kazuhiro Masuoka Breakdown of academic impact, for papers by Andrea Mengarelli Breakdown of academic impact, for papers by Roberta Schiavo Breakdown of academic impact, for papers by Rémy Duléry Breakdown of academic impact, for papers by Jean Norden Breakdown of academic impact, for papers by Karima Yakouben Breakdown of academic impact, for papers by D Baume Breakdown of academic impact, for papers by J.A. Gastaut Breakdown of academic impact, for papers by Adan Rios Breakdown of academic impact, for papers by Mats Remberger
Rankless by CCL
2026